X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Canadian Journal of Diabetes

期刊標題檢索 CAN J DIABETES 最新評論: Is the workload required for the paper large? Can only WB+pcr be subm... (2022-10-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Canadian Journal of Diabetes]您好,您是該頁面的第 19806 位訪客。

期刊簡介
期刊名稱Canadian Journal of Diabetes Canadian Journal of Diabetes
LetPub Score
6.2
50 ratings
Rate

Reputation
7.5

Influence
4.9

Speed
7.0

期刊簡稱CAN J DIABETES
ISSN1499-2671
E-ISSN2352-3840
h-index31
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.800.8290.784
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Internal Medicine
Q262 / 167
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q2114 / 244
Category: Medicine
Subcategory: Endocrinology
Q370 / 128

自引率 (2023-2024)8.70%自引率趨勢
掲載範囲
The Canadian Journal of Diabetes is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes health-care professionals.

Published bimonthly, the Canadian Journal of Diabetes contains original articles; reviews; case reports; shorter articles such as Perspectives in Practice, Practical Diabetes and Innovations in Diabetes Care; Diabetes Dilemmas and Letters to the Editor.
官方網站http://www.canadianjournalofdiabetes.com/
在線稿件提交https://www.editorialmanager.com/CJD
開放訪問No
出版商Elsevier Inc.
主題領域ENDOCRINOLOGY & METABOLISM
出版國/地區CANADA
發行頻率四半期刊行
創刊年2002
每年文章數81每年文章數趨勢
黃金OA百分比11.15%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ3125/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1499-2671%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Canadian Journal of Diabetes】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640688
    BIOMATERIALS569256
    BIOMEDICINE & PHARMACOTHERAPY498321
    Frontiers in Pharmacology486585
    Journal of Materials Chemistry B476054
    JOURNAL OF ETHNOPHARMACOLOGY475394
    Frontiers in Immunology457838
    COLLOIDS AND SURFACES B-BIOINTERFACES419206
    COMPUTERS IN BIOLOGY AND MEDICINE416232
    Frontiers in Oncology413344
  •  

    Canadian Journal of Diabetes Canadian Journal of Diabetes
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Canadian Journal of Diabetes] 的評論撰寫評論
作者: Calvin Veblen


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-20 21:47:34 評論於
Is the workload required for the paper large? Can only WB+pcr be submitted?
(0) 讚! | Calvin Veblen

作者: 泄矢泰和


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-19 17:17:49 評論於
Review Speed: 3.0 Experience Sharing: Just received a paper, sharing the submission experience, hoping it will be helpful to everyone. 5.17 submitted to journal. 5.20 under review. 8.9 major revision. 9.9 revision submitted to journal. 10.7 minor revision. 10.19 accepted
(0) 讚! | 泄矢泰和

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:10:41 評論於
Concise and clear titles directly reflect the core content of the article, often attracting attention and giving a comfortable feeling. At the same time, the title of SCI paper is beautiful and inspiring readers' interest
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:41:54 評論於
I am grateful for all the love and support you have given me throughout the years. Your kindness has been a guiding light in my life, and I am truly blessed to have you by my side
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:09:12 評論於
What kind of topics can impress the reviewers?
(0) 讚! | 北国博达

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:29:04 評論於
What kind of titles do reviewers generally prefer?
(0) 讚! | 北国博达

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 17:58:02 評論於
It's annoying. I had over 2 points for my publication last year, but this year it's only over 1 point. Will it have to decrease next year? Who would want to invest in it?!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 09:53:32 評論於
It's too harsh! After such a big drop, who dares to invest in the future??
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Canadian Journal of Diabetes] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*